{"name":"Intuitive Surgical","slug":"intuitive-surgical","ticker":"ISRG","exchange":"NASDAQ","domain":"intuitive.com","description":"Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performanc","hq":"Sunnyvale, CA","founded":0,"employees":"17021","ceo":"","sector":"Surgical Robotics","stockPrice":429.06,"stockChange":-3.21,"stockChangePercent":-0.74,"marketCap":"$152.0B","metrics":{"revenue":10582099968,"revenueGrowth":23,"grossMargin":66.3,"rdSpend":0,"netIncome":2979099904,"cash":4517300224,"dividendYield":0,"peRatio":52.3,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxOVDU0bmpRbWp2cjF6anN0TzRweFhIZkR3bll2R3U1bUxETzh3X0tfR2JpVkRSR3RzNDZING1lWE40cFNxQlJRZ1ZYMGE5cXNRNW9mRmFZUVplbUFrS3c1UXZzVXVEcnFpbnJZOXZmLTJSMlZZOHVUTmhIekVUN05nVnhFTFVhT2xrbDM5ZFhrQTZHTTA3RktKTE5zNC1jdjM1SmFqS2J2NndnTTg2NWtlYlFFbjd5YVp1REtxWlNza29QcHRR?oc=5","date":"2026-03-22","type":"pipeline","source":"AD HOC NEWS","summary":"Ionis Pharmaceuticals stock faces insider selling pressure amid pipeline anticipation on NASDAQ - AD HOC NEWS","headline":"Ionis Pharmaceuticals stock faces insider selling pressure amid pipeline anticipation on NASDAQ","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-21","type":"deal","source":"Indian Pharma Post","summary":"Max Institute partners with Intuitive Surgical to expand robotic-assisted surgery in India - Indian Pharma Post","headline":"Max Institute partners with Intuitive Surgical to expand robotic-assisted surgery in India","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxOeGRYamhHdDBSU3dWRC1oYjVNRVZBNTVZUVJ4aFJNNDltLW9QQ3NVRFZBVGxOdWhhSEZqYWU1T0VtVDVaQWNZQ2V6Qm0wd040eWVHU3N0MlA5akdJNUFFdlNWc1ZUT29rdDQ2ZGdQRjBET3RaNDFjekQxcHltYWh6TE4wcHRTMThyaUFEWDdQY1g2bDN3X25z?oc=5","date":"2026-01-14","type":"pipeline","source":"The Motley Fool","summary":"Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030 - The Motley Fool","headline":"Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxOU1ZTSW1TdXNaOXJITWJ0MTlHOXdDRkVwR19zaTl2MV82SWNWeGxzb29LeEhPZ2hqYlhNVW5fYnpGVnY4c1VRZ1Q1VnVvNVcyQ3h1YnBmTUxLdkZ2V25FX092QVhNVHlpYU91ZF9Ta2QtcjMwR0pLU2d1VTJFZkhjTXZtY29xZw?oc=5","date":"2026-01-03","type":"pipeline","source":"Nanalyze","summary":"5 Biotech Stocks We Like in 2026. And 5 We Don’t - Nanalyze","headline":"5 Biotech Stocks We Like in 2026. And 5 We Don’t","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxQWjYxa18wbC1qanh3Y0d5RkMxUmRwc0ItUmpSb0VETklBTWY3alZBQ01nZVp1RHh6WTNKQTBFSHlLSVI0SW9mdzl0M241RHZYZ1dTTkQ2dk9rZUxvWnNwbENLbUR2OE44QmJGUUdHLUlwYTQwYTlFbHBFYmM0aW9sdHI5dEpOTTNOZFdrSnBkc2NIaE9Ia3pqMG9qM2ZHSHF5YVhTSG0wckFLcGl4MTFIMnB5V1dZOVcxOC1jd3V2aDc5cGsteVJBQnA2Yw?oc=5","date":"2025-11-10","type":"pipeline","source":"bastillepost.com","summary":"Intuitive Fosun to accelerate localization in China's robotic surgery market: CEO - bastillepost.com","headline":"Intuitive Fosun to accelerate localization in China's robotic surgery market: CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxObFM2aG1ZdnJJb0dMUnptZlN1OC1WdkNSamlaM3FidF9rSHlwYlRLb2RFYWJISWFkVlMxLS1rc1Y0LVptSDc3d1hhRzZlVWlZeGxuX1hTcHJITWNRbXZGUzFjWjJFejlEcnhnSWxyR3RqMi04MHJBWmVrM3Q0QXNkLV9ZUVBtTkNLeXc?oc=5","date":"2025-09-17","type":"deal","source":"The Motley Fool","summary":"2 Growth Stocks to Buy and Hold Forever - The Motley Fool","headline":"2 Growth Stocks to Buy and Hold Forever","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQdGVVVTRuYW9vM0dBWklwZV9TQkYwS3FHOUhNbmdaQ2lRZmt1NTVKeHFadmEwN0tRUkFuOVphMjJDOHlKWDlBT2p0LU1fSGljM0c1c0xwZHBwTmpyODdXRDdLYm42bUtYbXl2X18tdmVVbTh2OHZ2b0s5OWozN1FjN01FWHNwMGdXRGkwd2RQT0QxckhzbUFGSDRPTG50MTYwLVA3WFhobUhCVEk?oc=5","date":"2025-04-28","type":"regulatory","source":"statnews.com","summary":"Tariffs are hitting surgical robots and pacemakers, but device companies aren’t sweating it, yet - statnews.com","headline":"Tariffs are hitting surgical robots and pacemakers, but device companies aren’t sweating it, yet","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNMmdSNldSYkhxVlRZUEZmaGNjWGRfVDl1RVFFNW9JNHVUVWhud3BpWDJoa2pPZDUxYUwzM0JJMEV6NDA1SlNKVVlOeGhDM29ZeVM0emo3Y3AyQWpucnlIQjdHM29ualFqYjg4U0VCZUJEaHRFTlVGTlRhLU9kU2t6Q216MXJGVEdudmMtT3hRZ09Fb3ZESF9ZYUxObDJYYkdRZVE3SmJHbWZqVzcx?oc=5","date":"2025-01-09","type":"pipeline","source":"Fierce Pharma","summary":"Mendaera hires chief commercial officer for handheld medical robot launch - Fierce Pharma","headline":"Mendaera hires chief commercial officer for handheld medical robot launch","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQWTZ4N2JXSjBmdnJOMjl5Q2ZnYmQxVmlhSUdkZ1ZaN0Jvbk1vTzV4bGpoV2ExRDVaRGdybG0zRkdrTjh3bFVVbWphZXh1aWxsZ3Jtcmh6akdrYUd0YWtkM19la183MzNQVFVpREk1NVdLT1ctRkRoM25uSElGSW1GUFpOZHg2QXBqWFFJSzlPbEgtQkEzdGk0X00yUEw?oc=5","date":"2023-11-30","type":"pipeline","source":"Medical Device and Diagnostic industry","summary":"Intuitive Surgical Teams with Chinese Company on Lung Cancer - Medical Device and Diagnostic industry","headline":"Intuitive Surgical Teams with Chinese Company on Lung Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxPdHgxTXZkb0xZT2J2NThaX3BqX3lGNnNzTndKT3JQNVdNbW0tUGFUQmNpY2RnbTkyVElTMTlFTGdqYlNCZFFTcnhuT2hXYXdTVC1NWUZHazNiWkFRZnJjODVRTmRJLWdGSWluNXM1VmhlM3drcHVhY0tQNnE2TGRlZUZHcHo?oc=5","date":"2023-11-12","type":"pipeline","source":"Yahoo Finance","summary":"Fosun Pharma prepares to deliver Da Vinci surgical robots to make advanced medical treatment affordable to Chinese patients - Yahoo Finance","headline":"Fosun Pharma prepares to deliver Da Vinci surgical robots to make advanced medical treatment affordable to Chinese patie","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxOU3ZzallTdE9NbTBwNmxZVnd4MV93dUYzdUY1VEhaOXM1VGZTRXNOdHg0T1dHMEI4MDk1Z2UzdGIwZkUzRjRJUWVGaWd1T3FqN3BVdFliZm05akh2RUVRMEp2cW1qTGRuZTZNR3JHd1dOLU0wVmRVSjBLVmlXejBTemZJWnhqZG1VWElNazV5LUpGaGs0SlJyMDc1T0c1UndJTXEzUS1EeUF3bjRhNUlFM1AySFZkUGFWM0tIZC1hMGdWMHpZMUE?oc=5","date":"2016-09-30","type":"pipeline","source":"Medical Design & Outsourcing","summary":"Intuitive Surgical And Fosun Pharma Establish Joint Venture Focused On Lung Cancer - Medical Design & Outsourcing","headline":"Intuitive Surgical And Fosun Pharma Establish Joint Venture Focused On Lung Cancer - Medical Design & Outsourcing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxQZHZmbDg4LVJpNmEwMnhhSVo2MEVQVThsMWdJUXl1TlY0cmdvVVJKaVlwNTBZaklmXzRKdXBMNHd6OTZUVlhyQWhpUFE1REFQOEZFOTNKbFh3bGZ2RGVEbVI2U090RTRGcVJna0JfRzdiLU1NRTRXZjhLcXRIUmNWT3N3ZEpxS3l2UUl0RFNxYmhRNE9pRzBQYVdZOEpUWHE3U0RtWGUwVF9VQnFhS3pLd003STlTdFd3MkFz?oc=5","date":"2016-09-29","type":"pipeline","source":"Fierce Biotech","summary":"Intuitive, Fosun Pharma launch $100M JV for robotic-assisted lung cancer Dx - Fierce Biotech","headline":"Intuitive, Fosun Pharma launch $100M JV for robotic-assisted lung cancer Dx","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"yahoo_finance","revenue":10064700000,"revenuePeriod":"2025-12-31","revenueHistory":[{"period":"2025-12-31","value":10064700000},{"period":"2024-12-31","value":8352100000},{"period":"2023-12-31","value":7124100000},{"period":"2022-12-31","value":6222200000}],"grossProfit":6642300000,"grossProfitHistory":[{"period":"2025-12-31","value":6642300000},{"period":"2024-12-31","value":5634200000},{"period":"2023-12-31","value":4729500000},{"period":"2022-12-31","value":4196000000}],"rdSpend":1311800000,"rdSpendHistory":[{"period":"2025-12-31","value":1311800000},{"period":"2024-12-31","value":1145300000},{"period":"2023-12-31","value":998800000},{"period":"2022-12-31","value":879000000}],"sgaSpend":2385000000,"operatingIncome":2945500000,"operatingIncomeHistory":[{"period":"2025-12-31","value":2945500000},{"period":"2024-12-31","value":2348900000},{"period":"2023-12-31","value":1766800000},{"period":"2022-12-31","value":1577100000}],"netIncome":2856000000,"netIncomeHistory":[{"period":"2025-12-31","value":2856000000},{"period":"2024-12-31","value":2322600000},{"period":"2023-12-31","value":1798000000},{"period":"2022-12-31","value":1322300000}],"eps":7.87,"epsHistory":[{"period":"2025-12-31","value":7.87},{"period":"2024-12-31","value":6.42},{"period":"2023-12-31","value":5.03},{"period":"2022-12-31","value":3.65}],"cash":3368000000,"cashHistory":[{"period":"2025-12-31","value":3368000000},{"period":"2024-12-31","value":2027400000},{"period":"2023-12-31","value":2750100000},{"period":"2022-12-31","value":1581200000}],"totalAssets":20458700000,"totalLiabilities":2517000000,"totalDebt":87000000,"equity":17824000000,"operatingCashflow":3030500000,"operatingCashflowHistory":[{"period":"2025-12-31","value":3030500000},{"period":"2024-12-31","value":2415000000},{"period":"2023-12-31","value":1813800000},{"period":"2022-12-31","value":1490800000}],"capex":-539800000,"capexHistory":[{"period":"2025-12-31","value":-539800000},{"period":"2024-12-31","value":-1111200000},{"period":"2023-12-31","value":-1064200000},{"period":"2022-12-31","value":-532400000}],"freeCashflow":2490700000,"dividendsPaid":null,"buybacks":-2295300000,"employees":17021,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":613300000,"ebit":855300000,"ebitda":1055300000,"period":"2026-03-31","revenue":2770800000,"epsBasic":2.31,"netIncome":821500000,"rdExpense":361900000,"epsDiluted":2.28,"grossProfit":1830500000,"operatingIncome":855300000},{"sga":687100000,"ebit":864300000,"ebitda":1085200000,"period":"2025-12-31","revenue":2866200000,"epsBasic":2.24,"netIncome":794800000,"rdExpense":352900000,"epsDiluted":2.21,"grossProfit":1904300000,"operatingIncome":864300000},{"sga":573300000,"ebit":759700000,"ebitda":919700000,"period":"2025-09-30","revenue":2505100000,"epsBasic":1.98,"netIncome":704400000,"rdExpense":329400000,"epsDiluted":1.95,"grossProfit":1662400000,"operatingIncome":759700000},{"sga":561200000,"ebit":743400000,"ebitda":890000000,"period":"2025-06-30","revenue":2440000000,"epsBasic":1.84,"netIncome":658400000,"rdExpense":313300000,"epsDiluted":1.81,"grossProfit":1617900000,"operatingIncome":743400000},{"sga":563400000,"ebit":578100000,"ebitda":727700000,"period":"2025-03-31","revenue":2253400000,"epsBasic":1.95,"netIncome":698400000,"rdExpense":316200000,"epsDiluted":1.92,"grossProfit":1457700000,"operatingIncome":578100000},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-09-30","revenue":null,"epsBasic":null,"netIncome":null,"rdExpense":null,"epsDiluted":null,"grossProfit":null,"operatingIncome":null}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":429.06,"previousClose":432.27,"fiftyTwoWeekHigh":603.88,"fiftyTwoWeekLow":417.74,"fiftyTwoWeekRange":"417.74 - 603.88","fiftyDayAverage":465.84,"twoHundredDayAverage":497.66,"beta":1.51,"enterpriseValue":148699365376,"forwardPE":36.4,"priceToBook":8.7,"priceToSales":14.36,"enterpriseToRevenue":14.05,"enterpriseToEbitda":38.27,"pegRatio":2.36,"ebitda":3885600000,"ebitdaMargin":36.7,"freeCashflow":2254087424,"operatingCashflow":3360800000,"totalDebt":0,"debtToEquity":0,"currentRatio":4.61,"returnOnAssets":10.2,"returnOnEquity":17.2,"analystRating":"1.9 - Buy","recommendationKey":"buy","numberOfAnalysts":29,"targetMeanPrice":576.91,"targetHighPrice":750,"targetLowPrice":378,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":0.6,"institutionHeldPercent":89.1,"sharesOutstanding":354162842,"floatShares":351967032,"sharesShort":6690532,"shortRatio":3.1,"shortPercentOfFloat":1.9,"epsTrailing":8.21,"epsForward":11.8,"revenuePerShare":29.7,"bookValue":49.31,"officers":[{"age":59,"name":"Dr. Gary S. Guthart Ph.D.","title":"Executive Chair"},{"age":57,"name":"Mr. David J. Rosa","title":"CEO & Director"},{"age":54,"name":"Mr. Jamie E. Samath","title":"Executive VP, CFO & Enterprise Technology Leader"},{"age":55,"name":"Mr. Gary H. Loeb J.D.","title":"Executive VP and Chief Legal & Compliance Officer"},{"age":55,"name":"Mr. Henry L. Charlton","title":"Executive VP and Chief Commercial & Marketing Officer"},{"age":58,"name":"Mr. Mark P. Brosius","title":"Executive VP and Chief Manufacturing & Supply Chain Officer"},{"age":null,"name":"Mr. Fredrik  Widman","title":"VP, Principal Accounting Officer & Corporate Controller"},{"age":null,"name":"Mr. Milind  Wagle","title":"Chief Information Officer"}],"industry":"Medical Instruments & Supplies","irWebsite":"http://investor.intuitivesurgical.com/phoenix.zhtml?c=122359&p=irol-IRHome","website":"https://www.intuitive.com","phone":"408 523 2100"}}